On Tuesday, New York Community Bancorp, Inc. (NYSE:NYCB)’s shares inclined 0.98% to $18.11.
New York Community Bancorp, Inc. (NYCB), the parent of New York Community Bank and New York Commercial Bank declared the appointment of Leslie D. Dunn-an practiced corporate law and governance professional and an accomplished businesswoman-to the Boards of Directors of the Company and the Banks, effective September 1, 2015.
A member of the Advisory Board of the Community Bank’s Ohio Savings Bank Division since its inception, Ms. Dunn has been an independent director of the Federal Home Loan Bank of Cincinnati since 2007, serving not only on its Audit and Compensation Committees, but also as Governance Committee Chair. In addition, Ms. Dunn is an independent director of E&H Family Group, Inc., an Ohio-based business that operates chains of supermarket and hardware stores. A member of the firm’s Finance Committee, she also serves as Compensation Committee Chair.
Ms. Dunn’s board experience also comprises over 15 years as a director of Telarc International Corporation, a Grammy Award-winning recording company, and service on the advisory board of Brown Flynn Communications.
New York Community Bancorp, Inc. operates as a holding company for New York Community Bank and New York Commercial Bank that offer banking products and financial services in New York, New Jersey, Florida, Ohio, and Arizona. The company offers various deposit products that comprise checking and savings accounts, individual retirement accounts, certificates of deposit, NOW and money market accounts, and non-interest-bearing accounts.
CF Industries Holdings, Inc. (NYSE:CF)’s shares gained 1.73% to $54.78.
CF Industries Holdings, Inc. (CF) declared that it has closed the acquisition of the outstanding interests it did not already own in GrowHow UK Limited (GrowHow) for total cash consideration of $580 million. GrowHow owns and operates nitrogen production facilities in Ince and Billingham, U.K.
This acquisition has raised CF Industries’ annual marketable nitrogen volume by about 450,000 short tons of gross ammonia; 600,000 short tons of ammonium nitrate; and 200,000 short tons of NPK compounds. Proceeding to the close of the transaction, GrowHow’s results were comprised of in CF Industries’ financial statements under Equity in Earnings of Non-Operating Associates – Net of Taxes.
CF Industries Holdings, Inc. manufactures and distributes nitrogen fertilizers and other nitrogen products worldwide. The company’s principal nitrogen fertilizer products comprise ammonia, granular urea, and urea ammonium nitrate solution.
At the end of Tuesday ‘s trade, Chubb Corp (NYSE:CB)‘s shares surged 0.56% to $121.04.
The Chubb Corporation (CB) of Insurance Companies has created an insurance product to assist protect professional services firms, media organizations and technology companies from errors and omissions (E&O), media liability and cyber exposures.
Chubb Professional PortfolioSM is a blended insurance product that assists provide a seamless approach to address these exposures, reduce potential coverage gaps and streamline the handling of claims. The product enables companies to customize their insurance protection by selecting one or more coverage parts:
- Miscellaneous Professional and Technology Services Liability – errors and omissions liability insurance for professional service firms counting those that may provide technology services in addition to professional services.
- Technology Products and Services Liability – errors and omissions liability insurance for information and network technology companies.
- MediaGuard – media liability insurance for companies that produce, promote or publish media, advertising or other content.
The Chubb Corporation, through its subsidiaries, provides property and casualty insurance to businesses and individuals. It offers personal insurance products for homes, valuable articles, homeowners, automobiles, and yachts; and personal liability, and personal accident and supplemental health insurance products.
BG Medicine, Inc. (NASDAQ:BGMD), ended its Tuesday ‘s trading session with -40.89% loss, and closed at $0.380.
BG Medicine, Inc. (BGMD) the developer of the BGM Galectin-3(R) Test, declared that on September 14, 2015, the Company was notified by The NASDAQ Stock Market LLC that trading in the Company’s common stock will be suspended on NASDAQ effective with the open of business on Wednesday, September 16, 2015, due to the Company’s continuing non-compliance with the stockholders’ equity requirement set forth in NASDAQ Listing Rule 5550(b) as of September 10, 2015. The September 10, 2015 date constituted the outside date by which the Company must remedy the listing deficiency in accordance with the discretion afforded the NASDAQ Listing Qualifications Hearings Panel under the NASDAQ Listing Rules. The Company understands that its common stock will be formally delisted from NASDAQ via NASDAQ’s filing of a Form 25 “Notification of Delisting” with the Securities Exchange Commission after all applicable review and appeal periods have lapsed.
BG Medicine, Inc., a commercial stage company, engages in developing and commercializing diagnostic products used to guide the patients suffering from heart failure and related disorders.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
